investorscraft@gmail.com

Intrinsic ValueAtomera Incorporated (ATOM)

Previous Close$2.93
Intrinsic Value
Upside potential
Previous Close
$2.93

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Atomera Incorporated operates in the semiconductor industry, specializing in advanced materials science to enhance transistor performance. The company's core revenue model is built on licensing its proprietary MST® (Mears Silicon Technology) to semiconductor manufacturers, enabling improved power efficiency and performance in integrated circuits. Atomera does not fabricate chips but instead provides a scalable, IP-driven solution that integrates seamlessly into existing manufacturing processes, targeting foundries and IDMs (Integrated Device Manufacturers). The semiconductor sector is highly competitive, with Atomera positioning itself as a technology enabler rather than a direct competitor to chipmakers. Its MST® technology addresses critical industry challenges such as power consumption and heat dissipation, which are pivotal for next-generation devices in AI, IoT, and 5G applications. While the company holds a niche position, its success hinges on widespread adoption by major semiconductor players, which remains a work in progress given the industry's cautious adoption cycles and high R&D barriers.

Revenue Profitability And Efficiency

Atomera reported modest revenue of $135,000 for FY 2024, reflecting its early-stage licensing focus. The company posted a net loss of $18.4 million, with diluted EPS of -$0.68, underscoring its pre-commercialization phase. Operating cash flow was negative at $13.2 million, with no capital expenditures, indicating heavy investment in R&D and business development rather than physical assets.

Earnings Power And Capital Efficiency

The company's earnings power remains constrained due to limited licensing agreements and high operating expenses. With no significant recurring revenue streams, Atomera's capital efficiency is currently low, as evidenced by its negative operating cash flow. The focus remains on scaling MST® adoption, which could improve margins if licensing gains traction with major semiconductor manufacturers.

Balance Sheet And Financial Health

Atomera maintains a solid liquidity position with $25.8 million in cash and equivalents, providing a runway for continued operations. Total debt is minimal at $1.98 million, resulting in a strong net cash position. The absence of dividends aligns with its growth-focused strategy, prioritizing reinvestment over shareholder payouts.

Growth Trends And Dividend Policy

Growth is contingent on broader adoption of MST® technology, which has yet to achieve commercial scale. The company does not pay dividends, reflecting its focus on reinvesting capital into R&D and market penetration. Future trends will depend on securing additional licensing deals and demonstrating the technology's value in high-volume production environments.

Valuation And Market Expectations

The market likely values Atomera based on its long-term potential rather than current financials, given its pre-revenue status in a high-growth industry. Investors appear to be betting on the eventual widespread adoption of MST®, though the timeline remains uncertain. The lack of profitability and reliance on licensing deals introduce significant volatility to its valuation.

Strategic Advantages And Outlook

Atomera's key advantage lies in its proprietary MST® technology, which addresses critical semiconductor performance challenges. However, the outlook is speculative, hinging on adoption by major industry players. Success would position the company as a key enabler of next-generation chips, but execution risks and competitive pressures remain high. Near-term focus will likely remain on partnerships and proving the technology's scalability.

Sources

Company filings (10-K), investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount